Chief, Digestive Disease Institute, North Shore University Hospital-Long Island Jewish Medical Center, Manhasset, New York; Associate Professor of Medicine, New York University School of Medicine, New ...

Ramat Gan, Israel, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs ...

Investigators led by Elisa Pose, MD, PhD, a research fellow in the Liver Unit at the Hospital Clínic de Barcelona in Barcelona, Spain, randomly assigned 237 patients with advanced, mostly ...

Please provide your email address to receive an email when new articles are posted on . Patients who received simvastatin plus rifaximin experienced similar rates of complications as those treated ...

Please provide your email address to receive an email when new articles are posted on . Patients who used statins had a reduced risk for HCC, hepatic decompensation and fibrosis progression.

As a hepatologist, Aleksander Krag has always sought to improve the prognosis of patients with liver disease, whom, he tells The Lancet, he often thinks of as a fictional patient he calls “Henry”. His ...

The new nomenclature for classifying steatotic liver disease (SLD) can help clinicians determine distinct prognoses, with the integration of alcohol intake as an aid in risk stratification, according ...

Compensated cirrhosis describes the stage of cirrhosis in which a person is not experiencing any symptoms. In severe cases, it can progress to decompensated cirrhosis. Cirrhosis is a progressive liver ...